Mir-5581-3p plays an inhibitory role in the progression of hepatocellular carcinoma (HCC) by regulating the expression of cardiolipin synthase 1 (CRLS1; Yin et al., 2019). Here, CRLS1 is linked to hepatocellular carcinoma.